Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Published loading...Updated

Philadelphia sues Eli Lily, CVS Caremark and others over high insulin costs

Summary by NBC Philadelphia
The City of Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing them of driving up the cost of insulin. In the lawsuit filed Tuesday, December 23, 2025, the city alleges that the companies engaged in an insulin pricing scheme that inflated the cost of diabetes medications. Named as defendants are pharmacy benefit managers CVS Caremark, Express Scripts, and OptumRx, along with drug man…

4 Articles

The city of Philadelphia sued several administrators and manufacturers of large pharmaceuticals on Tuesday, December 23, 2025, accusing them of inflating insulin prices through a fraudulent reimbursement scheme. According to the lawsuit, companies such as CVS Caremark, Express Scripts, OptumRx, Eli Lilly, Novo Nordisk and Sanofi increased the price of the drug. Although production costs about $2.00, prices have risen from about $20.00 in the 199…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Telemundo 62 broke the news in on Wednesday, December 24, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal